Resource center

Press Release

Genovac Acquires the Carterra LSA^® Instrument to Enable State-of-the-Art Antibody Screening and Characterization Services

Genovac becomes Carterra’s 100th LSA placement throughout the world. Fargo, North Dakota and Salt Lake City, Utah — April 20,…

• April 20, 2022

View

Press Release

Genovac to Present Latest Innovations in Antibody Discovery Against Difficult Targets at Antibody Engineering & Therapeutics Conference in San Diego

Fargo, North Dakota, Dec. 13, 2021 — Genovac, a contract research and manufacturing organization specializing in antibody discovery against challenging…

• December 13, 2021

View

Press Release

Genovac Adds Third Berkeley Lights Beacon®, Now Offers Cell Line Development

Genovac Becomes the First Contract Research Organization (CRO) to Leverage the Beacon Technology for Both Antibody Discovery and Cell Line…

• October 5, 2021

View

Article

Drug Discovery World: “Berkeley Lights: Improving antibody discovery”

Time can be the most valuable asset in the drug and therapeutic development processes, especially in situations like the COVID-19…

• May 27, 2021

View

Article

Forbes: “Meet the Collaboration Solving Some of Antibody Discovery’s Toughest Problems”

Today’s biotechnology scientists and companies are focused more on working together in the drug and therapy development process to benefit…

• May 26, 2021

View

Press Release

Leland Joins Genovac as Vice President of Characterization and Production

Fargo, N.D. (May 4, 2021) – Pete Leland, a 20-year veteran of the biotechnology industry, has joined Genovac Antibody Discovery,…

• May 4, 2021

View